These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11177222)

  • 1. A progestin-releasing intrauterine device for long-term contraception.
    Med Lett Drugs Ther; 2001 Jan; 43(1096):7-8. PubMed ID: 11177222
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [One year experience of levonorgestrel-releasing intrauterine device].
    Lähteenmäki P; Shain RN; Ratsula K; Toivonen J; Holden AE; Rosenthal M; Luukkainen T
    Duodecim; 1991; 107(1):26-31. PubMed ID: 1364704
    [No Abstract]   [Full Text] [Related]  

  • 4. The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.
    de Sá Rosa e Silva AC; Rosa e Silva JC; Nogueira AA; Petta CA; Abrão MS; Ferriani RA
    Fertil Steril; 2006 Sep; 86(3):742-4. PubMed ID: 16784745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levonorgestrel-releasing intrauterine device and uterine perforations.
    Prescrire Int; 2007 Dec; 16(92):248-9. PubMed ID: 18092420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abdominal migration of a levonorgestrel-releasing intrauterine device. Case report and review of the literature].
    Pont M; Lantheaume S
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):179-81. PubMed ID: 19303222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benefits of a levonorgestrel-releasing intrauterine device].
    Brun JL; Randriambelomanana J; Quiboeuf E; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 2009 May; 38 Spec No 3():F89-92. PubMed ID: 19736664
    [No Abstract]   [Full Text] [Related]  

  • 10. The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses.
    Chrisman C; Ribeiro P; Dalton VK
    Clin Obstet Gynecol; 2007 Dec; 50(4):886-97. PubMed ID: 17982331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expulsion rate among users of two models of intrauterine devices (IUD), the Multiload 375 and the levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena).
    Petta CA; Faundes D; Bahamondes L
    Eur J Obstet Gynecol Reprod Biol; 2009 Mar; 143(1):64; author reply 64-5. PubMed ID: 19150168
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrauterine contraception in adolescents and young women: a descriptive study of use, side effects, and compliance.
    Lara-Torre E; Spotswood L; Correia N; Weiss PM
    J Pediatr Adolesc Gynecol; 2011 Feb; 24(1):39-41. PubMed ID: 21262478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine contraception: an update.
    Bhathena RK; Guillebaud J
    J Obstet Gynaecol; 2008 Apr; 28(3):262-5. PubMed ID: 18569464
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC).
    van Vliet HA; Tchaikovski SN; Rosendaal FR; Rosing J; Helmerhorst FM
    Thromb Haemost; 2009 Apr; 101(4):691-5. PubMed ID: 19350113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese experience with intrauterine devices.
    Bilian X
    Contraception; 2007 Jun; 75(6 Suppl):S31-4. PubMed ID: 17531613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of levonorgestrel-releasing intrauterine system (LNG-IUS) uterine perforation.
    Margarit LM; Griffiths AN; Vine SJ
    J Obstet Gynaecol; 2004 Aug; 24(5):586-7. PubMed ID: 15369954
    [No Abstract]   [Full Text] [Related]  

  • 17. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
    Li CF; Lee SS; Pun TC
    Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Levonorgestrel releasing intrauterine spiral--contraception and therapeutic indications].
    Kunz J
    Praxis (Bern 1994); 2001 Mar; 90(11):442-52. PubMed ID: 11293937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
    Neven P; Amant F; Poppe W; Van den Broecke R
    Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.